The FTSE 100 firm said it still expects to earn between £550million and £570million in adjusted operating profits this year, ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...

The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

Prudential announced late Friday it has completed its share buyback programme launched in late June. The provider of life and health insurance and asset management in Asia and Africa bought back 81.4 ...

SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may ...

Durham non-profit among several to receive funding from GSK Denzel Washington rails against American politics: ‘You’re being ...

Durham Success Summit started five years ago and now many of the young men from the program have new careers outside Durham.

Wave Life Sciences has a 12-month low of $3.50 and a 12-month high of $16.74. In other news, major shareholder Plc Gsk acquired 2,791,930 shares of the firm’s stock in a transaction on Friday, ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Trump announced Thursday he'll nominate Robert F. Kennedy Jr. to be secretary of the Health and Human Services Department, ...